UNAIDS 90-90-90 HIV Strategy Expensive But Medically, Economically Beneficial, Study Says

Center for Global Health Policy’s “Science Speaks”: UNAIDS 90-90-90 strategy is cost-effective, will save millions of lives, study shows
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, writes, “Reaching [the] UNAIDS 90-90-90 goals, of 90 percent of people living with HIV diagnosed, 90 percent of those diagnosed accessing antiretroviral therapy, and treatment in at least 90 percent of those individuals suppressing their virus to undetectable levels, would not only benefit populations and improve individual health but would be cost-efficient, a study has found. The study, published in the Annals of Internal Medicine, used an HIV treatment and progression model to compare outcome data from the current HIV strategy used in South Africa to the UNAIDS target strategy…” (6/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.